About this product

Description

Description

While the WTO agreements do t regulate the use of biotechlogy per se, their rules can have a profound impact on the use of the techlogy for both commercial and n-commercial purposes. This book seeks to identify the challenges to international trade regulation that arise from biotechlogy. The contributions examine whether existing international obligations of WTO Members are appropriate to deal with the issues arising for the use of biotechlogy and whether there is a need for new international legal instruments, including a potential WTO Agreement on Biotechlogy. They combine various perspectives on and topics relating to genetic engineering and trade, including human rights and gender; intellectual property rights; traditional kwledge and access and benefit sharing; food security, trade and agricultural production and food safety; and medical research, cloning and international trade.

Author Biography

Daniel Wuger is a lecturer at the University of Bern, a senior research fellow at the Swiss Federal Office of Justice and a consultant to the NCCR International Trade Regulation project at the World Trade Institute, Bern. Thomas Cottier is Professor of European and International Economics Law at the University of Bern and Director of the Institute of European and International Economic Law. He is also Managing Director of the World Trade Institute.